China Regenerative Medicine International Limited
China Regenerative Medicine International Limited (HKSE: 8158) is trading at HK$0.26, about ₹3 at today's HKD/INR rate, as of 25 Sep 2026, 1:49 AM ET. Indian residents can buy China Regenerative Medicine International from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$0.26
Today's high
HK$0.26
52 week low
HK$0.18
52 week high
HK$0.75
8158 opened at HK$0.26, closed previously at HK$0.26, and has traded between HK$0.18 and HK$0.75 over the past 52 weeks.
About
China Regenerative Medicine International Limited operates as an investment holding entity, focusing on the development and distribution of a diverse portfolio of healthcare products and associated services. The company provides extensive health management solutions, covering health condition assessments, detoxification programs, fostering internal bodily balance, nourishing vital organs, and enhancing the immune system. Additionally, its beauty offerings encompass non-surgical medical aesthetics, essential dermatological care, anti-aging skin remedies, hair revitalization, skin firming treatments, localized body contouring, and intimate restoration services. Established in 1995, the organization was previously known as China Bio-Med Regeneration Technology Limited until its rebranding to China Regenerative Medicine International Limited in March 2015. Its headquarters are situated in Tsim Sha Tsui, Hong Kong.
Key statistics
Avg. volume
44.77K
Market cap
HK$77.58M
P/E Ratio
2.60
Price-to-sales ratio
0.72
Enterprise value
HK$114.01M
Free cash flow yield
20.05%
Debt-to-equity ratio
0.67
Return on equity
54.16%
ROIC
47.95%
Beta
-0.67
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
HK$72.06M
Earnings per share
HK$0.09
Free cash flow
HK$4.03M
Net profit margin
27.83%
Gross margin
56.41%
EBITDA
HK$8.26M
Revenue growth
-20.48%
Similar securities
This is not an investment recommendation
How to buy China Regenerative Medicine International from India
Indian residents can buy China Regenerative Medicine International shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for China Regenerative Medicine International and place an order
Find China Regenerative Medicine International by name or by its ticker, 8158, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. China Regenerative Medicine International trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your China Regenerative Medicine International position in HKD and INR. China Regenerative Medicine International pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in China Regenerative Medicine International from India
Trading and taxes when buying China Regenerative Medicine International from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneChina Regenerative Medicine International does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Estate or inheritance tax
- May applyHong Kong has no estate duty.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy China Regenerative Medicine International stock?
Yes. China Regenerative Medicine International (8158) has been listed on the Hong Kong Stock Exchange since 2001, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one China Regenerative Medicine International share cost in rupees?
One China Regenerative Medicine International share is HK$0.26 — about ₹3 at an HKD/INR rate of 12.23 on 25 Sep 2026. Both the China Regenerative Medicine International price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying China Regenerative Medicine International from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of China Regenerative Medicine International?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on China Regenerative Medicine International shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the China Regenerative Medicine International price. Paasa issues a capital-gains statement for your return.
Does China Regenerative Medicine International pay a dividend?
No. China Regenerative Medicine International does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade China Regenerative Medicine International from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on China Regenerative Medicine International shares held from India?
Hong Kong has no estate duty.
Do I have to declare China Regenerative Medicine International shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your China Regenerative Medicine International holding, its cost and its closing value.
How do I sell China Regenerative Medicine International and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.